Cite
Expression of epithelial–mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer
MLA
Kwan Ho Lee, et al. “Expression of Epithelial–mesenchymal Transition Driver Brachyury and Status of Tumor-Infiltrating CD8+ and FOXP3+ Lymphocytes in Predicting Treatment Responses to Neoadjuvant Chemotherapy of Breast Cancer.” Tumor Biology, vol. 39, May 2017. EBSCOhost, https://doi.org/10.1177/1010428317710575.
APA
Kwan Ho Lee, Eun Young Kim, Yong Lai Park, Sung-Im Do, Seoung Wan Chae, & Chan Heun Park. (2017). Expression of epithelial–mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer. Tumor Biology, 39. https://doi.org/10.1177/1010428317710575
Chicago
Kwan Ho Lee, Eun Young Kim, Yong Lai Park, Sung-Im Do, Seoung Wan Chae, and Chan Heun Park. 2017. “Expression of Epithelial–mesenchymal Transition Driver Brachyury and Status of Tumor-Infiltrating CD8+ and FOXP3+ Lymphocytes in Predicting Treatment Responses to Neoadjuvant Chemotherapy of Breast Cancer.” Tumor Biology 39 (May). doi:10.1177/1010428317710575.